Nat Rev Mol Cell Biol 11:688699
19, the National Association of Attorneys General submitted a letter to acting FDA commissioner Sara Brenner, MD, MPH, asking the agency to take decisive action against bad actors unlawfully profiting off the high demand for FDA-approved weight loss and diabetes drugs. While states play a role in protecting their own consumers, many organizations that sell unsafe, unregulated versions of GLP-1 operate outside the country, the letter stated
Del Olmo-Garcia, M
Wegovy SELECT trial cardiovascular outcomes
Personalized GLP-1 care built for you Our treatment plans start with your data, history, and goals, and your medication is compounded to match
They may need hospital-based assessment, blood tests, heart evaluation, or specialist care